These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Translimbal laser photocoagulation to the trabecular meshwork as a model of glaucoma in rats. Levkovitch-Verbin H, Quigley HA, Martin KR, Valenta D, Baumrind LA, Pease ME. Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):402-10. PubMed ID: 11818384 [Abstract] [Full Text] [Related]
8. Resistance of retinal ganglion cells to an increase in intraocular pressure is immune-dependent. Bakalash S, Kipnis J, Yoles E, Schwartz M. Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2648-53. PubMed ID: 12147598 [Abstract] [Full Text] [Related]
9. [The neuroprotective effect of erigeron breviscapus (vant) hand-mazz on retinal ganglion cells after optic nerve crush injury]. Jiang B, Jiang YQ. Zhonghua Yan Ke Za Zhi; 2003 Aug; 39(8):481-4. PubMed ID: 14642169 [Abstract] [Full Text] [Related]
10. A new calcium channel antagonist, lomerizine, alleviates secondary retinal ganglion cell death after optic nerve injury in the rat. Karim Z, Sawada A, Kawakami H, Yamamoto T, Taniguchi T. Curr Eye Res; 2006 Mar; 31(3):273-83. PubMed ID: 16531285 [Abstract] [Full Text] [Related]
11. Neuroprotective effect of 4-(Phenylsulfanyl)butan-2-one on optic nerve crush model in rats. Chien JY, Sheu JH, Wen ZH, Tsai RK, Huang SP. Exp Eye Res; 2016 Feb; 143():148-57. PubMed ID: 26472213 [Abstract] [Full Text] [Related]
12. Alpha2-adrenoreceptor agonists are neuroprotective in a rat model of optic nerve degeneration. Yoles E, Wheeler LA, Schwartz M. Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):65-73. PubMed ID: 9888428 [Abstract] [Full Text] [Related]
13. The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Jehle T, Dimitriu C, Auer S, Knoth R, Vidal-Sanz M, Gozes I, Lagrèze WA. Graefes Arch Clin Exp Ophthalmol; 2008 Sep; 246(9):1255-63. PubMed ID: 18414890 [Abstract] [Full Text] [Related]
14. Quantitative analysis of retinal ganglion cell survival with Rbpms immunolabeling in animal models of optic neuropathies. Kwong JM, Quan A, Kyung H, Piri N, Caprioli J. Invest Ophthalmol Vis Sci; 2011 Dec 28; 52(13):9694-702. PubMed ID: 22110060 [Abstract] [Full Text] [Related]
15. Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury. Johnson EC, Cepurna WO, Choi D, Choe TE, Morrison JC. Invest Ophthalmol Vis Sci; 2014 Dec 18; 56(1):412-9. PubMed ID: 25525172 [Abstract] [Full Text] [Related]
16. A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy. Ben Simon GJ, Bakalash S, Aloni E, Rosner M. Am J Ophthalmol; 2006 Jun 18; 141(6):1105-11. PubMed ID: 16765680 [Abstract] [Full Text] [Related]
17. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice. Zhong L, Bradley J, Schubert W, Ahmed E, Adamis AP, Shima DT, Robinson GS, Ng YS. Invest Ophthalmol Vis Sci; 2007 Mar 18; 48(3):1212-8. PubMed ID: 17325165 [Abstract] [Full Text] [Related]
18. Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Ishii Y, Kwong JM, Caprioli J. Invest Ophthalmol Vis Sci; 2003 May 18; 44(5):1982-92. PubMed ID: 12714633 [Abstract] [Full Text] [Related]
19. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma. Crandall J, Matragoon S, Khalifa YM, Borlongan C, Tsai NT, Caldwell RB, Liou GI. Ophthalmic Res; 2007 May 18; 39(2):69-75. PubMed ID: 17284931 [Abstract] [Full Text] [Related]
20. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Hains BC, Waxman SG. Invest Ophthalmol Vis Sci; 2005 Nov 18; 46(11):4164-9. PubMed ID: 16249495 [Abstract] [Full Text] [Related] Page: [Next] [New Search]